Article Information
History
- May 23, 2022.
Article Versions
- You are currently viewing Version 1 of this article (May 23, 2022 - 09:45).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Alvin X. Han, Ph.D.1,*,
- Amy Toporowski, M.D.2,
- Jilian A. Sacks, Ph.D.3,
- Mark Perkins, M.D.3,
- Sylvie Briand, M.D.3,
- Maria van Kerkhove, Ph.D.3,
- Emma Hannay, Ph.D.2,
- Sergio Carmona, M.D.2,
- Bill Rodriguez, M.D.2,
- Edyth Parker, Ph.D.4,
- Brooke E. Nichols, Ph.D.1,2,5,† and
- Colin A. Russell, Ph.D.1,5,†,*
- 1Department of Medical Microbiology & Infection Prevention, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands
- 2Foundation for Innovative New Diagnostics (FIND), Geneva, Switzerland
- 3Department of Epidemic and Pandemic Preparedness and Prevention, Emergency Preparedness Programme, World Health Organization, Geneva, Switzerland
- 4Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA
- 5Department of Global Health, School of Public Health, Boston University, Boston, MA, USA
- ↵*Correspondence to Alvin X. Han (x.han{at}amsterdamumc.nl) and Colin A. Russell (c.a.russell{at}amsterdamumc.nl)
↵† Contributed equally
Posted May 23, 2022.
Low testing rates limit the ability of genomic surveillance programs to monitor SARS-CoV-2 variants: a mathematical modelling study
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos